GSK Pharmaceuticals' earnings per share in India FY 2015-2023

Published by A. Minhas, Aug 2, 2023
The Earnings Per Share for GSK Pharmaceuticals in India during fiscal year 2023 was valued at 35.72 Indian rupees. This was a sharp increase from the previous year. In financial year 2023, GSK ranked as the leading brand in the anti-infectives and dermatology segment.

Earnings per share of GSK Pharmaceuticals Limited in India from financial year 2015 to 2023 (in Indian rupees)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

June 2023

Region

India

Survey time period

FY 2015 to FY 2023

Supplementary notes

*Retrospectively adjusted for September 2018 bonus issue for all the prior years.

**Without considering exceptional items, Earnings per equity share for the FY 2020 period would be INR 2.01, FY 2021 would be INR 16.92, FY 2022 would be INR 22.23, and FY 2023 would be INR 35.7.

One Indian rupee is equal to 0.011 euros and 0.012 U.S. dollars (as of August 2023).

India's fiscal year starts in April and ends in March. For example, FY 2018 started in April 2017 and ended in March 2018.

Values for FY 2021 and 2022 are prepared according to Ind AS105, hence the values are not comparable with prior years.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " GlaxoSmithKline Pharmaceuticals Limited India "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you GlaxoSmithKline Pharmaceuticals Limited India

Market overview

6

GSK India - key figures

6

Product portfolio

3

Main competitiors

4

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

GlaxoSmithKline Pharmaceuticals Limited IndiaGlobal pharmaceutical industrySanofiPfizerJohnson & Johnson
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu